Literature DB >> 18755691

KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3.

Xiangwei Huang1, Xia Li, Bin Guo.   

Abstract

KLF6 (Kruppel-like factor 6) is a zinc finger transcription factor and a tumor suppressor that is frequently mutated in prostate cancer. KLF6 suppresses tumor growth and induces apoptosis in cancer cells through mechanisms still not defined. Here we show that KLF6 induces apoptosis in prostate cancer cells by ATF3 (activating transcription factor 3) expression. KLF6 binds directly to and activates the ATF3 promoter. ATF3 induced apoptosis when ectopically expressed in cells, whereas knockdown of ATF3 by small interference RNA blocked KLF6-induced apoptosis. KLF6 mutants derived from clinical prostate cancers failed to activate the ATF3 promoter and were unable to induce apoptosis. Furthermore, stress conditions (exposure to staurosporine and hypoxia induced by sodium azide) caused significant increase in ATF3 expression and induced apoptosis, whereas knockdown of KLF6 by small interference RNA blocked the increase of ATF3 as well as the induction of apoptosis in these conditions. Thus, ATF3 is a key mediator of KLF6-induced apoptosis in prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755691      PMCID: PMC2573052          DOI: 10.1074/jbc.M802515200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.

Authors:  T Mashima; S Udagawa; T Tsuruo
Journal:  J Cell Physiol       Date:  2001-09       Impact factor: 6.384

2.  The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.

Authors:  Sucharita Bandyopadhyay; Ying Wang; Rui Zhan; Sudha K Pai; Misako Watabe; Megumi Iiizumi; Eiji Furuta; Sonia Mohinta; Wen Liu; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Yukio Takano; Ken Saito; Therese Commes; David Piquemal; Tsonwin Hai; Kounosuke Watabe
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

3.  The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas.

Authors:  A E Allen-Jennings; M G Hartman; G J Kociba; T Hai
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

4.  A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.

Authors:  Goutham Narla; Analisa Difeo; Helen L Reeves; Daniel J Schaid; Jennifer Hirshfeld; Eldad Hod; Amanda Katz; William B Isaacs; Scott Hebbring; Akira Komiya; Shannon K McDonnell; Kathleen E Wiley; Steven J Jacobsen; Sarah D Isaacs; Patrick C Walsh; S Lilly Zheng; Bao-Li Chang; Danielle M Friedrichsen; Janet L Stanford; Elaine A Ostrander; Arul M Chinnaiyan; Mark A Rubin; Jianfeng Xu; Stephen N Thibodeau; Scott L Friedman; John A Martignetti
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

Review 5.  Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models.

Authors:  M H Jamerson; M D Johnson; R B Dickson
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

Review 6.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis.

Authors:  T Hai; M G Hartman
Journal:  Gene       Date:  2001-07-25       Impact factor: 3.688

7.  Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling.

Authors:  Viqar Syed; Kasturi Mukherjee; James Lyons-Weiler; Kin-Mang Lau; Tetsuo Mashima; Takashi Tsuruo; Shuk-mei Ho
Journal:  Oncogene       Date:  2005-03-03       Impact factor: 9.867

8.  In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.

Authors:  G Narla; S Kremer-Tal; N Matsumoto; X Zhao; S Yao; K Kelley; M Tarocchi; S L Friedman
Journal:  Oncogene       Date:  2007-02-05       Impact factor: 9.867

9.  A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.

Authors:  X Yin; J W Dewille; T Hai
Journal:  Oncogene       Date:  2007-10-22       Impact factor: 9.867

10.  Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.

Authors:  Dan Lu; Curt D Wolfgang; Tsonwin Hai
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

View more
  56 in total

1.  Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.

Authors:  Mario R Calderon; Mark Verway; Beum-Soo An; Analisa DiFeo; Tarek A Bismar; David K Ann; John A Martignetti; Tali Shalom-Barak; John H White
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

2.  Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.

Authors:  Chun-Han Chen; Po-Hsien Huang; Po-Chen Chu; Mei-Chuan Chen; Chih-Chien Chou; Dasheng Wang; Samuel K Kulp; Che-Ming Teng; Qianben Wang; Ching-Shih Chen
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

Review 3.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

4.  ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types.

Authors:  Anderly C Chüeh; Janson W T Tse; Michael Dickinson; Paul Ioannidis; Laura Jenkins; Lars Togel; BeeShin Tan; Ian Luk; Mercedes Davalos-Salas; Rebecca Nightingale; Matthew R Thompson; Bryan R G Williams; Guillaume Lessene; Erinna F Lee; Walter D Fairlie; Amardeep S Dhillon; John M Mariadason
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

Review 5.  Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Authors:  Adrian P Bracken; Kristian Helin
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

6.  Fine mapping analysis confirms and strengthens linkage of four chromosomal regions in familial hypospadias.

Authors:  Cilla Söderhäll; Izabella Baranowska Körberg; Hanh T T Thai; Jia Cao; Yougen Chen; Xufeng Zhang; Zu Shulu; Loes F M van der Zanden; Iris A L M van Rooij; Louise Frisén; Nel Roeleveld; Ellen Markljung; Ingrid Kockum; Agneta Nordenskjöld
Journal:  Eur J Hum Genet       Date:  2014-07-02       Impact factor: 4.246

7.  Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.

Authors:  Feng Xin; Dong-Wei Yao; Li Fan; Jiu-Hua Liu; Xiao-Dong Liu
Journal:  Clin Exp Med       Date:  2019-08-28       Impact factor: 3.984

8.  KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.

Authors:  XiaoMei Liu; Alejandro Gomez-Pinillos; Charisse Loder; Enrique Carrillo-de Santa Pau; Ruifang Qiao; Pamela D Unger; Ralf Kurek; Carole Oddoux; Jonathan Melamed; Robert E Gallagher; John Mandeli; Anna C Ferrari
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

9.  The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.

Authors:  Saisai Wei; Hongbo Wang; Chunwan Lu; Sarah Malmut; Jianqiao Zhang; Shumei Ren; Guohua Yu; Wei Wang; Dale D Tang; Chunhong Yan
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

10.  Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.

Authors:  Christophe Bureau; Naima Hanoun; Jérôme Torrisani; Jean-Pierre Vinel; Louis Buscail; Pierre Cordelier
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.